Monday, October 18, 2021
Home Tags Cipla

Tag: Cipla

Cipla gets USFDA nod for generic Difluprednate Ophthalmic Emulsion

Drug firm Cipla on Thursday said it has received approval from the US health regulator to market Difluprednate Ophthalmic Emulsion, used in the treatment of...

DCGI allows Cipla to import Moderna vaccine in India

The Drugs Controller General of India (DCGI) has granted permission to pharma major Cipla to import Moderna's C-19 vaccine for restricted emergency...

Cipla gets USFDA nod for Inhalation product

Cipla yesterday said that it has received final approval from the US health regulator for Arformoterol Tartrate Inhalation Solution, used to treat...

Cipla launches Vitamin C Chewable Tablets with Gold Supplement

Mumbai: Maxirich, the flagship health supplement brand of Cipla Health Ltd. has introduced two new products - Maxirich Vitamin C+ Zinc Chewable Tablets and Maxirich Gold Advanced Daily Supplement...

New price of Remdesivir injection, prices reduced by 7 companies: NPPA

Prices of Remdesivir injection have been voluntarily curtailed by various drug companies on the intervention of the government, National Pharmaceutical Pricing Authority...

Cipla doubles Remdesivir production to meet demand

India's Cipla Ltd has doubled production of C-19 medication remdesivir to help meet "unprecedented demand" as the country battles a massive second wave of infections, the drugmaker said...

Govt to pharma firms: Ramp up Remdesivir Mfg to full capacity

The government said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity...

Maha FDA proposes to NPPA to bring Remdesivir Inj under price...

In view of the increasing incidence of C-19 infection in the state, the Maharashtra Food and Drug Administration (FDA) has directed C-19...

Cipla gets US FDA approval for generic drug for Migraine

Cipla Limited has received final approval for its Abbreviated New Drug Application (ANDA) for sumatriptan nasal spray, 20 mg from the United...

Focus on quality to change perception on drugs from India

Focus on quality to change perception on drugs from India: Pharma chiefs In the early days of the pandemic...

Indian Pharma firms to set local Mfg of APIs: No dependence...

Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house in a bid to...

Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug

New Delhi: Drug major Cipla is recalling over 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the US...

Cipla launches rapid antigen test kit

Cipla announced its partnership with the Premier Medical Corporation for commercialisation of the rapid antigen test kits for C-19 in India. The...

Cipla inks licensing deal with Belgium antibody test kit

New Delhi: Drug major Cipla on Wednesday said it signed a licensing agreement with a Belgium-based MultiG for the distribution of their C-19 rapid antibody test kit, across most emerging markets...

90% pharma marketers say non-transparency is a major bottleneck

90% Pharmaceutical marketers are of the view that non-transparency of ‘doctor reach and results’ is a major bottleneck in adoption of digital...

Cipla to market ICMR approved ELISA testing kit in India

Cipla announced the commercialisation of antibody detection kits for C-19 in India in partnership with KARWA under the technology transfer from the...

Zydus Cadila & Cipla gets USFDA nod for dimethyl fumarate DR...

Zydus Cadila Zydus Cadila has received final approval from the USFDA to market dimethyl fumarate delayed-release capsules, (US...

Buy Remdesivir only at hospitals: FDA

PUNE: The Food and Drug Administration (FDA) on Wednesday, while confirming the arrival of 20,000 vials of remdesivir in Pune division, said patients’ relatives...

Remdesivir shortage in India is easing

India’s supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID-19 medicine at hospitals, said Kedar...

देश में बनी कोरोना की सस्ती दवा लॉन्च के लिए तैयार

नई दिल्ली। देश में तैयार कोरोना संक्रमण के इलाज की दवा लॉन्च के लिए तैयार है। इस भारतीय दवा को बेहद सस्ती और...

A more affordable Favipiravir soon

What: Pharmaceutical firm Cipla is all set to launch a more affordable version of Favipiravir, for the treatment of Covid-19 patients. An off-patent antiviral...

Cipla launches generic version of remdesivir at Rs 4,000 per vial

Pharma major Cipla on Wednesday said it has launched its generic version of antiviral drug remdesivir at Rs 4,000 per vial, which is among the...

Mylan gets go-ahead to make remdesivir

New Delhi: After Hetero and Cipla, another pharmaceutical major Mylan was given permission by India's drug regulator on Thursday to manufacture and market the...

These are the prices of Remdesivir by Gilead, Hetero & Cipla

Gilead Sciences Inc has priced its Covid-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some...

Latest posts

Drugs Technical Advisory Board (DTAB): Minutes of meetings

Download minutes of meetings: Drugs Technical Advisory Board (DTAB) This division deals with...

Authors

50 POSTS0 COMMENTS
30 POSTS0 COMMENTS
15 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS